Literature DB >> 22081579

Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces.

Yohei Watanabe1, Fumiko Nagai, Masami Morotomi.   

Abstract

Isolation, cultivation, and characterization of the intestinal microorganisms are important for understanding the comprehensive physiology of the human gastrointestinal (GI) tract microbiota. Here, we isolated two novel bacterial strains, YIT 12067(T) and YIT 12068, from the feces of healthy human adults. Phylogenetic analysis indicated that they belonged to the same species and were most closely related to Phascolarctobacterium faecium ACM 3679(T), with 91.4% to 91.5% 16S rRNA gene sequence similarities, respectively. Substrate availability tests revealed that the isolates used only succinate; they did not ferment any other short-chain fatty acids or carbohydrates tested. When these strains were cocultured with the xylan-utilizing and succinate-producing bacterium Paraprevotella xylaniphila YIT 11841(T), in medium supplemented with xylan but not succinate, their cell numbers became 2 to 3 orders of magnitude higher than those of the monoculture; succinate became undetectable, and propionate was formed. Database analysis revealed that over 200 uncultured bacterial clones from the feces of humans and other mammals showed high sequence identity (>98.7%) to YIT 12067(T). Real-time PCR analysis also revealed that YIT 12067(T)-like bacteria were present in 21% of human fecal samples, at an average level of 3.34 × 10(8) cells/g feces. These results indicate that YIT 12067(T)-like bacteria are distributed broadly in the GI tract as subdominant members that may adapt to the intestinal environment by specializing to utilize the succinate generated by other bacterial species. The phylogenetic and physiological properties of YIT 12067(T) and YIT 12068 suggest that these strains represent a novel species, which we have designated Phascolarctobacterium succinatutens sp. nov.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081579      PMCID: PMC3255759          DOI: 10.1128/AEM.06035-11

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  49 in total

1.  Extensive set of 16S rRNA-based probes for detection of bacteria in human feces.

Authors:  Hermie J M Harmsen; Gerwin C Raangs; Tao He; John E Degener; Gjalt W Welling
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

2.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

Review 3.  Diversity of the human gastrointestinal tract microbiota revisited.

Authors:  Mirjana Rajilić-Stojanović; Hauke Smidt; Willem M de Vos
Journal:  Environ Microbiol       Date:  2007-09       Impact factor: 5.491

Review 4.  Approaches to the study of the systematics of anaerobic, gram-negative, non-sporeforming rods: current status and perspectives.

Authors:  Haroun N Shah; Ingar Olsen; Kathy Bernard; Sydney M Finegold; Saheer Gharbia; Radhey S Gupta
Journal:  Anaerobe       Date:  2009-08-18       Impact factor: 3.331

5.  Succinispira mobilis gen. nov., sp. nov., a succinate-decarboxylating anaerobic bacterium.

Authors:  P H Janssen; K A O'Farrell
Journal:  Int J Syst Bacteriol       Date:  1999-07

6.  Alistipes indistinctus sp. nov. and Odoribacter laneus sp. nov., common members of the human intestinal microbiota isolated from faeces.

Authors:  Fumiko Nagai; Masami Morotomi; Yohei Watanabe; Hiroshi Sakon; Ryuichiro Tanaka
Journal:  Int J Syst Evol Microbiol       Date:  2009-08-10       Impact factor: 2.747

7.  Metagenomic analysis of the human distal gut microbiome.

Authors:  Steven R Gill; Mihai Pop; Robert T Deboy; Paul B Eckburg; Peter J Turnbaugh; Buck S Samuel; Jeffrey I Gordon; David A Relman; Claire M Fraser-Liggett; Karen E Nelson
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

8.  Towards the human intestinal microbiota phylogenetic core.

Authors:  Julien Tap; Stanislas Mondot; Florence Levenez; Eric Pelletier; Christophe Caron; Jean-Pierre Furet; Edgardo Ugarte; Rafael Muñoz-Tamayo; Denis L E Paslier; Renaud Nalin; Joel Dore; Marion Leclerc
Journal:  Environ Microbiol       Date:  2009-07-06       Impact factor: 5.491

9.  DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting.

Authors:  N Akopyanz; N O Bukanov; T U Westblom; S Kresovich; D E Berg
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

10.  In-feed administered sub-therapeutic chlortetracycline alters community composition and structure but not the abundance of community resistance determinants in the fecal flora of the rat.

Authors:  S P J Brooks; E Kheradpir; M McAllister; J Kwan; K Burgher-McLellan; M Kalmokoff
Journal:  Anaerobe       Date:  2009-08       Impact factor: 3.331

View more
  64 in total

Review 1.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

2.  The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome.

Authors:  Vijay Shankar; Daniel Homer; Laura Rigsbee; Harry J Khamis; Sonia Michail; Michael Raymer; Nicholas V Reo; Oleg Paliy
Journal:  ISME J       Date:  2015-01-30       Impact factor: 10.302

3.  Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet.

Authors:  Matthew R Panasevich; E M Morris; S V Chintapalli; U D Wankhade; K Shankar; S L Britton; L G Koch; J P Thyfault; R S Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-10       Impact factor: 4.052

4.  Phascolarctobacterium faecium abundant colonization in human gastrointestinal tract.

Authors:  Feifan Wu; Xianfeng Guo; Jiachun Zhang; Min Zhang; Zihao Ou; Yongzheng Peng
Journal:  Exp Ther Med       Date:  2017-08-03       Impact factor: 2.447

5.  Association of gut microbial communities with plasma lipopolysaccharide-binding protein (LBP) in premenopausal women.

Authors:  Jessica S Citronberg; Keith R Curtis; Emily White; Polly A Newcomb; Katherine Newton; Charlotte Atkinson; Xiaoling Song; Johanna W Lampe; Meredith Aj Hullar
Journal:  ISME J       Date:  2018-02-12       Impact factor: 10.302

6.  Intrinsic aerobic capacity governs the associations between gut microbiota composition and fat metabolism age-dependently in rat siblings.

Authors:  Satu Pekkala; Sanna Lensu; Miriam Nokia; Sanja Vanhatalo; Lauren G Koch; Steven L Britton; Heikki Kainulainen
Journal:  Physiol Genomics       Date:  2017-10-13       Impact factor: 3.107

7.  Subclinical Cytomegalovirus Infection Is Associated with Altered Host Immunity, Gut Microbiota, and Vaccine Responses.

Authors:  Clarissa Santos Rocha; Lauren A Hirao; Mariana G Weber; Gema Méndez-Lagares; W L William Chang; Guochun Jiang; Jesse D Deere; Ellen E Sparger; Jeffrey Roberts; Peter A Barry; Dennis J Hartigan-O'Connor; Satya Dandekar
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

8.  Properties of Probiotics Kocuria SM1 and Rhodococcus SM2 Isolated from Fish Guts.

Authors:  S M Sharifuzzaman; Hafizur Rahman; Dawn A Austin; B Austin
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

9.  Phylogenetic distribution of three pathways for propionate production within the human gut microbiota.

Authors:  Nicole Reichardt; Sylvia H Duncan; Pauline Young; Alvaro Belenguer; Carol McWilliam Leitch; Karen P Scott; Harry J Flint; Petra Louis
Journal:  ISME J       Date:  2014-02-20       Impact factor: 10.302

10.  Gut Microbiota Analysis in Rats with Methamphetamine-Induced Conditioned Place Preference.

Authors:  Tingting Ning; Xiaokang Gong; Lingling Xie; Baomiao Ma
Journal:  Front Microbiol       Date:  2017-08-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.